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 ABSTRACT  
Introduction  The risk of mortality from cardiovascular disease (CVD) is higher in 
wintertime throughout the world, but it is not known if this reflects annual changes in diet or 
lifestyle, or an endogenous photoperiodic mechanism that is sensitive to changes in 
daylength.  
Methods  Phenotypic data on cardiometabolic and lifestyle factors were collected throughout 
a 4 year time period from 502,642 middle-aged participants in UK Biobank.  To assess the 
impact of seasonal environmental changes on cardiovascular risk factors, we linked these 
data to the outdoor temperature and day length at the time of assessment. Self-reported 
information on physical activity, diet and disease status were used to adjust for confounding 
factors related to health and lifestyle.  
Results  Mortality related to CVD was higher in winter, as were risk factors for this condition 
including blood pressure, markers of inflammation and BMI.  These seasonal rhythms were 
significantly related to day length after adjustment for other factors that might affect 
seasonality including physical activity, diet and outdoor temperature. 
Conclusions  The risk of CVD may be modulated by day length at temperate latitudes, and 
the implications of seasonality should be considered in all studies of human cardiometabolic 
health.  
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Key messages: 
In this cross-sectional study in UK Biobank we report annual variations in cardiovascular risk factors 
and mortality that were associated with day length independent of environmental and lifestyle factors. 
These seasonal changes in day length might contribute to annual patterns in cardiovascular disease 
and mortality. 
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 Introduction 
Seasonality of human disease is a prominent feature underpinning the epidemiology of many 
infectious; (1) cardiovascular and/or cerebrovascular; (2-8) inflammatory;(9) and neuropsychiatric 
diseases. (10) For example, the prevalence and severity of rhinovirus infection is greatly increased in 
autumn and winter, independent of the outdoor temperature.(1, 11) The risks of experiencing an acute 
cardiovascular event, and of dying as a consequence, are also increased in winter.(12) By contrast, 
relapses of multiple sclerosis are more frequent in summer, and directly correlate with plasma levels 
of melatonin, the pineal hormone that regulates seasonality.(9)  Seasonal rhythms in mood are widely 
reported, particularly at far northern latitudes, with short day lengths in winter associated with 
depressed mood and tiredness, often in conjunction with increased body weight,(10) all evidence that 
the human body is sensitive to annual changes in day length. 
 
Seasonal patterns in disease are reciprocated by seasonality in many mechanisms fundamental to 
physiology, including gene transcription,(13, 14) immune function,(13, 15) metabolism,(16-21) and 
mood and neurobiological parameters.(22-24) Although seasonality is a core feature of human health 
and disease, it is not known whether annual variations are driven by endogenous photoperiodic 
mechanisms that entrain to day length or are a direct consequence of seasonal patterns in lifestyle and 
environmental factors. 
 
Human seasonality is poorly understood, but the factors that regulate seasonality have been rigorously 
investigated in animal models. These studies suggest that annual day length change is the single most 
important modulator of seasonal variation in physiology in classically photoperiodic species, such as 
hamsters, sheep and deer. In these animals, seasonality is an innate response mediated through 
neurobiological mechanisms that are sensitive to day length, principally involving upregulation of 
central thyroid-hormone signaling and neuroplasticity in response to light-regulated secretion of 
melatonin.(25) These daylength-dependent neurobiological and neuroendocrine changes are 
associated with profound annual variation in fertility, metabolism, behavior, and immune function. 
(26-29) 
Ac
ce
pte
d M
nu
scr
ipt
 Intriguingly, the mechanisms that regulate photoperiodic responses in animals are retained in the 
human brain;(30, 31) however, it is unclear how they regulate human physiology, or if they contribute 
to the annual variation that influences human susceptibility to disease. 
 
CVD is the leading cause of death worldwide; excess deaths in winter increase its burden on global 
health and understanding the mechanisms underlying seasonal variations may help in identifying 
preventive interventions.  The aim of this study was to use data from a UK population cohort study to 
investigate whether daylength was associated with seasonal variations in CVD mortality and relevant 
intermediate phenotypes after adjusting for lifestyle and other environmental factors that vary by 
season.   
 
 
DESIGN & METHODS 
 
Study Sample and Design 
We analysed data from UK Biobank, a general population cohort study that recruited 502,642 
participants continuously between 2006 and 2010, at 21 assessment centers located across the UK 
(Supplementary Table S1).  Inclusion in the present study was restricted to participants who reported 
having no chronic disease at the time of recruitment, except for studies of mortality that included the 
entire database. 
 
Outcomes 
Body mass index (BMI), waist circumference, body fat percentage (assessed by bioelectric 
impedance), blood pressure, heart rate and white blood cell counts were measured by trained UK 
Biobank staff using standardized methods and instruments.(32)  Sleep duration was the self-reported 
number of hours sleep including naps in every 24 hours. Mortality from CVD was derived from 
national death certificate data that had already been linked to UK Biobank data (Supplementary 
Methods).   
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 Cardiovascular Disease Risk Factors 
Potential confounders included as covariables were age; sex; ethnicity; Townsend area-deprivation 
score;(32) physical activity and sedentary behavior; alcohol intake and smoking status; location of the 
UK Biobank assessment center and the time of day that blood pressure, heart rate were measured.  
Full details of how these parameters were derived are given in the Supplementary Methods.  Diet was 
assessed using two methods; firstly, the number of portions of fruit and vegetables eaten per day was 
self-reported by the whole study cohort.  This question referred to average consumption over the last 
12 months.  A more comprehensive analysis of diet was available for a subset of the cohort, consisting 
of a 24h dietary recall assessment, from which we derived the total food volume, energy and fat intake 
per day.   
 
 
Environmental Variables 
The day length and outdoor temperature at the time and place of residence of each participant were 
measured using public weather databases (Supplementary Methods) 
 
Statistical Analyses 
Histograms were used to inspect the distribution of the data, and appropriate transformations were 
applied to continuous variables that did not conform to the parameters of the normal distribution 
(eosinophil, basophil and monocyte percentages).  Seasonal patterns were analyzed using multiple 
regression to fit a linearized cosinor model (details of this procedure are in Supplementary Methods) 
for each outcome of interest against the time variable, month (Supplementary Figure S1-15).  
Seasonality was indicated by (i) statistical significance of the estimated cosinor (sine and cosine) 
regression coefficients; (ii) improved fit following addition of the cosinor terms to the model, inferred 
by difference in Akaike information criterion (AIC) when the cosinor terms were added to 
multivariable regression model; and (iii) the likelihood ratio 2 test statistic, defined as twice the 
difference in log likelihood of the multivariable model, with and without the cosinor terms.  If 
seasonality was indicated, we next investigated if these patterns were linearly related to day length, 
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 independent of lifestyle and environmental factors.  Three models were run that included an 
increasing number of covariables and progressively adjusted for sociodemographic, disease, lifestyle 
and environmental (temperature and day length) factors, with results reported as point estimates with 
standard errors. The numbers of participants recruited to UK Biobank was not identical at each month 
(Supplementary  Table 1) and to exclude a confounding effect of such sample inequality, we re-
analysed all significant outcome variables applying a weighting factor based on the inverse 
probability of participating in UK Biobank at each month.  All analyses were performed using Stata 
14 statistical software (StataCorp, College Station, TX) unless otherwise indicated, and statistical 
significance was accepted at values of p < 0.05. 
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 RESULTS 
Participants 
The sociodemographic, lifestyle and health characteristics of the 185,479 female and 143,858 male 
UK Biobank participants who met the inclusion criteria for this study are shown in Supplementary 
Table S3; equivalent to 66.5% and 66.1% of the total number of female and male participants, 
respectively.  The cohort were predominantly White (95%), and aged between 55-64 years.  Their 
average body mass index (BMI) was 26.4±0.1 for women, and 27.3 ±0.01 for men (mean ± sem).  
Weighting for the numbers of participants recruited to UK Biobank by month (Supplementary Table 
S1), had negligible effects on the statistical significance of the outcome variables in this analysis 
(Supplementary Table S4).  The data were stratified by sex due to the differences in response to 
daylength between men and women reported in previous studies of seasonality in UK Biobank.(33) 
 
Dietary Factors 
Diet was assessed in the full dataset using self-reported consumption of fruit and vegetables, and this 
was found to be seasonal (Figure 1 D; Supplementary Figure S8), with acrophase occurring in summer 
(July). The adjusted linear model of the relationship between this dietary parameter and day length 
indicated that such seasonality was independent of outdoor temperature among women but not men 
(Table 1). Seasonality of dietary intake was also assessed using a 24-hour dietary recall questionnaire 
completed by a subset of the participants in summer (June–August; n = 83,278) and winter (October–
December; n = 103,805).  As for the self-reported data on fruit and vegetable intake, the dietary recall 
questionnaire revealed that energy and fat intake and the total weight of food consumed were higher 
in summer compared to winter (Figure 1A-C).   
 
Lifestyle Factors 
Seasonality was also evident in lifestyle factors, with more physical activity and less sedentary 
behavior in summer than winter (Table 2; Supplementary Figure S3). These parameters were 
independently associated with day length after adjustment for confounding factors (Table 1). Sleep 
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 duration was not seasonally patterned among women (likelihood ratio test, P>0.05), whereas there 
was a statistically weak seasonal pattern among men, of slightly increased sleep duration in winter 
(likelihood ratio test, P=0.01) (Table 2; Supplementary Figure S5).  Accordingly, sleep duration was 
not directly related to day length after adjustment for temperature, neither in women nor in men 
(Table 1).   
 
Cardiovascular risk factors 
Blood Pressure 
Seasonality was also evident in systolic and diastolic blood pressure (Figure 2 (A); Supplementary 
Figure S1), with acrophase in winter (December–January), and nadir in summer (June), coinciding 
with the winter and summer solstices, respectively.  The amplitude of this seasonal effect amounted to 
2.02 and 1.95mmHg systolic blood pressure in men and women respectively.  These patterns were 
daylength-dependent, independent of sex, physical activity, sedentary behavior and outdoor 
temperature (Table 1).   
 
Body Composition 
Body composition also showed seasonality, with BMI, body fat percentage and waist circumference 
all higher in winter than in summer (Figure 2 (B-D); Table 2). In contrast to the association with 
blood pressure, seasonality in BMI lagged behind the photoperiod change, in that acrophase and nadir 
were closely aligned with the equinoxes when daily hours of light and darkness are equal (Figure 2).  
The seasonal acrophase for body composition occurred in February/March in men and women, while 
seasonal peaks in food intake occurred much later, in July/August (Figure 1).  The amplitude of the 
seasonal peaks in BMI amount to 0.17 and 0.12 kg/m
2
 for men and women respectively, and this 
equated to a mean seasonal difference of 0.99 kg body weight for men, and 0.79 kg for women.  The 
seasonal changes in BMI peaked at the times of maximal changes in day length (equinox), while 
seasonal changes in food intake occurred when day length was most stable (solstice).  The 
relationship between BMI and day length was statistically significant and independent of confounding 
factors (Table 1).   
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White Blood Cell Counts 
The total number of peripheral white blood cells, as well as the percentage of each cell type, is shown 
in Supplementary Table S3 and Supplementary Figure S9.  Mean monthly data with fitted seasonal 
models for the percentage of lymphocytes, monocytes, neutrophils and eosinophils are shown in Table 
3. The neutrophil-to-lymphocyte ratio was taken as an overall index of inflammatory cells. (34) This 
parameter showed strong seasonality (Figure 2(E)), with the acrophase occurring in winter (January) 
and the nadir in summer (June) among men. Other than monocytes in both sexes, and eosinophils in 
women, all white blood cell percentages were significantly related to day length in both men and 
women (Table 1). These associations were independent of confounding factors, including outdoor 
temperature. 
 
Mortality 
Of all 502,642 UK Biobank participants, 1,442 died from CVD over 9 years of follow-up (2006-2015) 
(Figure 3).  Monthly all-cause mortality was higher in the winter months.  To assess the effects of 
seasonality on CVD mortality, monthly totals of deaths from CVD were expressed as percentage of 
total annual deaths, and the monthly mean percentage CVD death across the nine year follow-up was 
higher in the winter months (Figure 3).  
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 DISCUSSION 
The present study found clear seasonal variations in CVD risk factors and mortality among a middle-
aged population living at temperate latitude. The data are in agreement with reports of higher 
incidence of metabolic syndrome components (obesity, dysglycaemia and hypertension) in winter,(19, 
35) which were directly and inversely related to the hours of sunlight and outdoor temperature.(4, 18, 
19, 36)  The variations observed in the present study were directly related to day length, independent 
of outdoor temperature or seasonal lifestyle patterns. Our findings, therefore, support accumulating 
evidence that innate photoperiod-responsive seasonality in human physiology could contribute to 
annual variation in disease susceptibility.(13) 
 
Our finding of higher CVD mortality in winter versus summer was in agreement with previous 
studies.(37, 38)  Elevated CVD mortality in winter occurs worldwide, even in countries with mild 
winter temperatures;(37, 39) however, countries at the Equator that have constant annual photoperiods 
do not report such an increase.(37)  Temperature cannot completely account for this difference as the 
greatest effect is found at mid-latitudes around the Tropics; by contrast, far-Northern countries with 
low temperatures (e.g. Iceland and Russia) have low-amplitude seasonal variation in CVD 
mortality(37) and gene expression.(13)  This suggests that other factors, such as photoperiod, may 
contribute to seasonality and could modulate human susceptibility to CVD.  
 
We detected seasonal variation in white blood cells, with levels for most cell types higher in winter 
than in summer. Previous population-based studies have also reported wintertime increases in white 
blood cells and other inflammatory markers.(13, 15) These relationships were retained, but inverted, 
in the southern hemisphere, suggesting that day length, rather than month, could underpin the 
effect.(13)  Our data confirm these findings in the largest sample size to date, and show that seasonal 
variations in white blood cell count were independent of demographic and lifestyle factors. By 
excluding participants with chronic disease from our analysis of relationships with daylength, we 
focused on homeostatic mechanisms underlying immunity; therefore, it is unlikely that seasonality 
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 was driven by disease in this instance, and further studies are now warranted to see if these patterns 
are retained in disease. 
 
Previous studies demonstrated that seasonality in immune function mirrored transcriptional patterns of 
proinflammatory genes,(13) and it is likely that photoperiodic modulation of immunity contributes to 
winter increases in the prevalence and severity of disease.(4, 13) Of note, day length exerts potent 
effects on immune function among photoperiodic animals, independent of temperature or other 
environmental factors.  In animals, seasonal changes in immunity optimize survival in challenging 
winter conditions by amplifying the numbers of immunosurveillant white blood cells in conjunction 
with suppression of innate immunity, including inflammation and behavioral signs of an acute phase 
response, such as anorexia and social withdrawal.(27, 40) Remarkably, these changes are a direct 
response to day length, and can be reproduced by exposure to short day length in the laboratory.(27, 
40)   Changes in immunity are not confined to overtly seasonal species and animals that are not 
classically photoperiodic, and that do not exhibit photoperiodic regulation of fertility, such as rats and 
C57BL/6J strains of laboratory mice, retain photoperiodic modulation of immune function.(27, 41)  
Our data lend support to the concept that seasonal variation in human immunity might also be driven 
by innate mechanisms that synchronize with annual changes in photoperiod.  
 
Components of the metabolic syndrome (hypertension, diabetes mellitus and obesity) vary according 
to the time of year, with disease most likely in winter.(20, 42)  Such annual variation was higher and 
associated with comorbid mood disorders, at northern latitudes where photoperiodic changes are 
profound.(10)  To our knowledge, there has been just one long-term experimental study that measured 
seasonal changes in food intake and body weight in a study in the US that reported increased food 
intake in autumn.(21) In contrast, in the present study, food intake tended to increase earlier, peaking 
in the summer months.  The participants in the US study
21
 were younger (mean 31 years) and thinner 
(23.4kg/m
2
), and lived in less variable annual photoperiods of lower latitudes, all of which might 
contribute to the discrepancy in seasonal peaks of food intake with the present study.   
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 Seasonal changes in BMI closely tracked the times of year when day length deviated from equivalent 
hours of light and dark (equinoxes) when the rate of change of daylength is maximal, which further 
supports regulation by a mechanism that is entrained by annual photoperiodic change. The magnitude 
of the seasonal effect on BMI has potential clinical significance; we found a 0.99-kg increase in body 
weight between September and March among men, whereas previous studies reported a 0.5-kg 
seasonal increase among obese individuals(16) and a 0.48-kg increase among the general 
population.(17)  Seasonal changes in body composition were of higher amplitude and more closely 
related to day length among women than men in the present study. Women could exhibit increased 
sensitivity to photoperiodic modulation of metabolism, as evidenced by increased seasonality in 
females previously reported for mood disorders.(24)  Winter festivals were not thought to contribute 
to annual changes in BMI in previous studies, as the rate of weight gain began to increase before 
festival season.(17, 35)  Similarly, the trend for increasing BMI as day length decreased preceded the 
timing of Christmas and New Year holidays in the UK among the present cohort. Photoperiod can 
regulate food intake and body composition in animals,(43) and the same mechanisms might underlie 
the relationship between day length and BMI found in our study. 
 
Sleep duration was not strongly seasonal in the present study, and was weakly related to day length 
among men only. This finding is in agreement with reports of minimal effects of season on sleep in 
modern times when artificial light has removed restrictions on activities in the hour of darkness.(44) 
Experimental studies that enforced natural seasonal photoperiods (i.e. 14-h darkness in winter) did 
report increased sleep duration during short photoperiods.(45)  Nonetheless, artificial light has 
confined exposure to such long periods of darkness to the research laboratory, and human sleep 
duration in seems minimally affected by day length.   
 
The variance in cardiovascular risk factors that we report relates to the human seasonality at a 
population level and its implications for the individual requires further investigation.  In addition to 
this, the magnitude of seasonal variation in cardiovascular risk factors was small, and the implications 
of such marginal changes for susceptibility to disease are unknown.  It is a limitation that sleep and 
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 dietary information were self-reported and not-quantitative, and that seasonal data were collected over 
only a 4-year time period, and from a sample of middle-aged participants that do not represent the 
general UK population.  The principal strength of this study is the large sample size, and the 
combination of health, demographic and environmental data at the time and place of assessment for 
each participant.  To our knowledge, no previous study of human seasonality has linked seasonal and 
health data at such fine resolution, nor had the capacity to adjust for multiple lifestyle-related 
confounders in a large dataset. 
 
Innate mechanisms that regulate seasonal physiology might have evolved to allow humans to 
accommodate the variable day lengths they encountered as they migrated northwards from their 
evolutionary birthplace under constant photoperiods of equatorial regions.  Constant exposure to low-
level indoor light in the urban environment could disrupt these mechanisms, and might favor the 
‘winter’ phenotype of increased blood pressure, inflammation, adiposity and BMI.  Our findings of 
daylength-dependent variation in CVD risk factors among a large cohort of urban participants 
suggests that evolutionary mechanisms are retained, and remain sensitive to annual photoperiodic 
changes despite the constant light and temperature of modern life. The implications for the seasonal 
dimension in human health and susceptibility to disease, including the role of exposure to artificial 
light and erratic lifestyles, must now be considered.  
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Figure Legends 
Figure 1:  Food Intake was Higher in Summertime in UK Biobank Participants 
Dietary intake was higher in summer (Jun–Aug) compared to autumn and winter (Oct–Dec) 
in a subset of 54,228 participants who completed 24-h food recall during these months in 
2011. The Data are given as the mean + 95% confidence interval for (A) weight of food, (B) 
total energy intake and (C) total fat ingested per day. (D, E) Evidence of seasonal patterns of 
food intake was also evident in the dietary information that was available from the whole UK 
Biobank cohort (n=503,655), with summertime peaks in the numbers of portions of fruit and 
vegetables eaten per day (D)  = acrophase; ***p<0.001. 
 
Figure 2: Seasonal Patterns in Cardiometabolic Parameters   
Significant seasonal variation was detected in systolic blood pressure (A), body mass index 
(B), body fat percentage (C), waist circumference (D), and neutrophil-to-lymphocyte ratio (E) 
shown here for male participants who were free from chronic disease.  = acrophase.   
 
Figure 3: Seasonal Patterns in CVD Mortality  
Seasonal variation was similarly evident in the number of CVD-related deaths, with the 
highest mortality in the winter.   
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 Table 1: Association between Day Length and Cardiometabolic and Lifestyle Parameters 
 
Women (n = 181,991) 
Parameter b, (se)  Model 1  
P 
value 
 Model 2  
P 
value 
 
Model 3  
P 
value 
 
Cardiometabolic* 
 
 
   
 
   
 
  
 
Systolic blood pressure 
 -0.423 
(0.015) 
 <0.001  
-0.422 
(0.014) 
 <0.001  
-0.205 
(0.024) 
 <0.001  
Diastolic blood pressure 
 -0.147 
(0.009) 
 <0.001  
-0.144 
(0.008) 
 <0.001  
-0.147 
(0.013) 
 <0.001  
Heart rate 
 -0.074 
(0.008) 
 <0.001  
-0.063 
(0.008) 
 <0.001  
-0.041 
(0.014) 
 <0.01  
BMI 
 -0.005 
(0.003) 
 >0.05  
0.009 
(0.003) 
 <0.01  
0.040 
(0.006) 
 <0.001  
Waist circumference 
 -0.048 
(0.009) 
 <0.001  
-0.013 
(0.008) 
 >0.05  
-0.009 
(0.014) 
 >0.05  
Body fat percentage 
 -0.046 
(0.005) 
 <0.001  
-0.020 
(0.005) 
 <0.01  
0.043 
(0.008) 
 <0.001  
 
 
            
White blood cells (%) 
 
            
Lymphocytes 
 0.080 
(0.005) 
 <0.001  
0.073 
(0.005) 
 <0.001  
0.110 
(0.009) 
 <0.001  
Monocytes  
 0.005 
(0.000) 
 <0.001  
0.005 
(0.000) 
 <0.001  
0.000 
(0.000) 
 <0.05  
Neutrophils 
 -0.125 
(0.006) 
 <0.001  
-0.117 
(0.006) 
 <0.001  
-0.117 
(0.010) 
 <0.001  
Eosinophils 
 0.002 
(0.000) 
 <0.01  
0.002 
(0.000) 
 <0.01  
-0.001 
(0.000) 
 <0.01  
Basophils  
 0.007 
(0.000) 
 <0.001  
0.007 
(0.000) 
 <0.001  
0.007 
(0.000) 
 <0.001  
Neutrophil:Lymphocyte Ratio 
 -0.010 
(0.000) 
 <0.001  
-0.010 
(0.000) 
 <0.001  
-0.013 
(0.001) 
 <0.001  
 
 
            
Lifestyle and diet 
 
            
Physical activity 
 0.542 
(0.040) 
 <0.001  
0.428 
(0.040) 
 <0.001  
0.107 
(0.066) 
 <0.05  
Sedentary behaviour 
 -0.017 
(0.001) 
 <0.001  
-0.014 
(0.001) 
 <0.001  
0.011 
(0.002) 
 <0.001  
Sleep duration 
 -0.003 
(0.000) 
 <0.001  
-0.003 
(0.000) 
 <0.001  
0.001 
(0.001) 
 >0.05  
Fruit and vegetable intake  
0.062 
(0.003) 
 <0.001  
0.056 
(0.003) 
 <0.001  
0.016 
(0.004) 
 <0.001  
 
 
            
Men (n=140,305) 
  Model 1  
P 
value 
 Model 2  
P 
value 
 Model 3  
P 
value 
 
Cardiometabolic 
 
            
Systolic blood pressure  
-0.422 
(0.015) 
 <0.001  
-0.418 
(0.015) 
 <0.001  
-0.111 
(0.026) 
 <0.001  
Diastolic blood pressure  
-0.178 
(0.009) 
 <0.001  
-0.168 
(0.009) 
 <0.001  
-0.122 
(0.015) 
 <0.001  
Heart rate  
-0.157 
(0.010) 
 <0.001  
-0.144 
(0.010) 
 <0.001  
-0.078 
(0.017) 
 <0.001  
BMI   
-0.010 
(0.003) 
 <0.01  
-0.003 
(0.003) 
 >0.05  
0.043 
(0.005) 
 <0.001  
Waist circumference  
-0.050 
(0.009) 
 <0.001  
-0.024 
(0.009) 
 <0.001  
0.028 
(0.014) 
 <0.05  
Body fat percentage  
-0.099 
(0.005) 
 <0.001  
-0.084 
(0.005) 
 <0.001  
0.019 
(0.008) 
 <0.05  
 
 
            
White blood cells (%) 
 
 
 
 
 
 
          
Lymphocytes 
 0.047 
(0.005) 
 <0.001  
0.045 
(0.005) 
 <0.001  
0.061 
(0.009) 
 <0.001  
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 Monocytes 
 0.004 
(0.000) 
 <0.001  
0.004 
(0.000) 
 <0.001  
0.001 
(0.000) 
 <0.05  
Neutrophils 
 -0.085 
(0.006) 
 <0.001  
-0.083 
(0.006) 
 <0.001  
-0.078 
(0.010) 
 <0.001  
Eosinophils 
 0.001 
(0.000) 
 <0.001  
0.002 
(0.000) 
 <0.05  
-0.002 
(0.001) 
 <0.001  
Basophils 
 0.006 
(0.000) 
 <0.001  
0.006 
(0.000) 
 <0.001  
0.005 
(0.000) 
 <0.001  
Neutrophil:Lymphocyte Ratio 
 -0.010 
(0.000) 
 <0.001  
-0.010 
(0.001) 
 <0.001  
-0.010 
(0.001) 
 <0.001  
 
 
            
Lifestyle and diet 
 
            
Physical activity  
0.420 
(0.061) 
 <0.001  
0.363 
(0.061) 
 <0.001  
0.366 
(0.103) 
 <0.001  
Sedentary behaviour  
-0.018 
(0.002) 
 <0.001  
-0.015 
(0.002) 
 <0.001  
0.0123 
(0.003) 
 <0.001  
Sleep duration  
-0.004 
(0.000) 
 <0.001  
-0.005 
(0.001) 
 <0.001  
0.001 
(0.001) 
 >0.05  
Fruit and vegetable intake  
0.038 
(0.003) 
 <0.001  
0.035 
(0.003) 
 <0.001  
-0.005 
(0.005) 
 >0.05  
 
 
            
 
Cardiometabolic, lifestyle, diet and white blood cell percentages are shown for women (top) and men (bottom). Data are expressed as 
regression coefficients (b), with standard errors (se) in parentheses. A p-value of < 0.05 was considered statistically significant. 
Abbreviation: BMI, body mass index. 
 
Model 1 was adjusted for age, ethnicity, deprivation, and location of UK Biobank center. 
Model 2 was adjusted for age, ethnicity, deprivation, location of UK Biobank center, physical activity, BMI, alcohol intake, sedentary 
behavior, fruit and vegetable intake and smoking status. 
Model 3 was adjusted for age, ethnicity, deprivation, location of UK Biobank center, physical activity, BMI, alcohol intake, sedentary 
behavior, fruit and vegetable intake, smoking, and mean outdoor temperature. 
 
In addition to the covariates listed above, the time of day that measurements were collected was included in Model 3 for blood pressure and 
all white blood cell counts, and the blood count device was included in Model 3 for all white blood cell counts 
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 Table 2 Assessment of Statistical Significance of Seasonality by Comparison of Linear Models and 
Cosinor Parameters 
      WOMEN                                                                
Parameter   
Multivariable Regression Estimate 
b(se) 
   
Likelihood 
Ratio Test 
 
Acrophase 
(month) 
Amplitude  
  
Sine 
coefficient 
P 
value 
 
Cosine 
coefficient 
P 
value 
 AIC  LR2 
P 
value 
   
 
                
Cardiometabolic                
Systolic blood pressure  
-0.788 
(0.067) 
<0.001  
-1.460 
(0.265) 
<0.001  
-
124.6 
 128.6 <0.001  Jan 1.92 
 
Diastolic blood pressure  
-0.478 
(0.038) 
<0.001  
-0.477 
(0.144) 
<0.01  
-
162.8 
 166.8 <0.001  Dec 0.64 
 
Heart rate  
-0.143 
(0.040) 
>0.05  
-0.249 
(0.151) 
>0.05  -8.9  12.9 >0.05  NA NA 
 
BMI  
-0.036 
(0.017) 
<0.05  
-0.644 
(0.062) 
<0.001  
-
113.3 
 117.3 <0.001  Mar 0.12 
 
Waist circumference  
-0.130 
(0.041) 
<0.01  
-0.332 
(0.152) 
<0.05  -6.6  10.5 <0.01  Feb 0.23 
 
Body fat (%)  
-0.172 
(0.024) 
<0.001  
-1.301 
(0.0878) 
<0.001  
-
215.5 
 219.6 <0.001  Feb 0.28 
 
                
White blood cells (%)                
Lymphocytes   
0.250 
(0.023) 
<0.001  
-0.077 
(0.085) 
>0.05  
-
156.9 
 160.9 <0.001  May 0.33 
 
Monocytes  
0.001 
(0.001) 
>0.05  
-0.000 
(0.004) 
>0.05  2.8  1.2 >0.05  NA NA 
 
Neutrophils  
-0.303 
(0.027) 
<0.001  
0.047 
(0.100) 
>0.05  
-
165.5 
 169.5 <0.001  Dec 0.49 
 
Eosinophils  
0.001 
(0.002) 
>0.05  
0.019 
(0.006) 
>0.01  -7.8  11.8 <0.01  NA NA 
 
Basophils  
0.015 
(0.001) 
<0.001  
-0.018 
(0.004) 
<0.001  
-
434.8 
 438.9 <0.001  Jun 0.03 
 
Neutrophil: Lymphocyte 
Ratio 
 
-0.035 
(0.003) 
<0.001  
0.013 
(0.011) 
>0.05  
-
180.8 
 184.8 <0.001  Jan 0.04 
 
Lifestyle and diet                
Physical activity  
-0.800 
(0.197) 
>0.05  
-4.48 
(0.723) 
<0.05  -36.1  40.2 >0.05  NA NA 
 
Sedentary behaviour  
0.006 
(0.007) 
<0.001  
-0.102 
(0.027) 
<0.001  -19.6  23.6 <0.001  Feb 0.10 
 
Sleep Duration 
 -0.003 
(0.004) 
>0.05  
-0.033 
(0.014) 
<0.05  -1.9  5.9 >0.05  NA NA 
 
Fruit and vegetable 
intake 
 
0.100 
(0.013) 
<0.001  
0.284 
(0.047) 
<0.001  -66.1  70.1 <0.001  Jul 0.31 
 
 
 
   
 
 
 
         
 
MEN 
Parameter   
Multivariable Regression Estimate 
b(se) 
   
Likelihood 
Ratio Test 
 
Acrophase 
(month) 
Amplitude  
  
Sine 
coefficient 
P 
value 
 
Cosine 
coefficient 
P 
value 
 AIC  LR2 
P 
value 
    
Cardiometabolic                
Systolic blood pressure  
-0.521 (-
0.0751) 
<0.001  
-1.408 (-
0.278) 
<0.001  -49.5  53.6 <0.001  Jan 2.02  
Diastolic blood pressure  
-0.389 (-
0.0438) 
<0.001  
-0.385 (-
0.162) 
<0.05  -77.4  81.4 <0.001  Jan 0.81  
Heart rate  
-0.073 (-
0.0497) 
>0.05  
0.477 (-
0.184) 
<0.01  -10.9  14.9 <0.01  Jan 0.77  
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 BMI  
0.0691 (-
0.016) 
<0.001  
-0.195 (-
0.0571) 
<0.001  -50.4  54.5 <0.001  Feb 0.17  
Waist circumference  
0.235 (-
0.0432) 
<0.001  
0.726 (-
0.154) 
<0.01  -32  36.0 <0.001  Feb 0.41  
Body fat (%)  
-0.0025 (-
0.0226) 
>0.05  
-0.253 (-
0.0809) 
<0.001  -7.8  11.8 <0.01  Jan 0.56  
                
*White blood cells (%)                
Lymphocytes  
0.197 
(0.026) 
<0.001  
0.049 
(0.094) 
>0.05  -62.6  66.6 <0.001  May 0.24  
Monocytes  
-0.000 
(0.001) 
>0.05  
-0.009 
(0.004) 
<0.05  -1.1  5.1 >0.05  NA NA  
Neutrophils  
-0.251 
(0.031) 
<0.001  
-0.126 
(0.110) 
>0.05  -70.1  74.0 <0.001  Dec 0.39  
Eosinophils  
-0.006 
(0.002) 
<0.01  
0.007 
(0.007) 
>0.05  -12.6  16.6 <0.01  Sep 0.04  
Basophils  
0.013 
(0.001) 
<0.001  
-0.003 
(0.003) 
<0.05  -247  251.0 <0.001  Jun 0.03  
Neutrophil:Lymphocyte 
Ratio 
 
-0.032 
(0.004) 
<0.001  
-0.024 
(0.014) 
<0.05  -70.2  74.2 <0.001  Jan 0.04  
Lifestyle and diet                
Physical activity  
-0.997 (-
0.30) 
<0.01  
-8.802 
(1.094) 
<0.001  -60.9  64.9 <0.01  Jan 8.80  
Sedentary behaviour  
-0.024 (-
0.010) 
<0.05  
-0.238 
(0.036) 
<0.001  -39.6  43.7 <0.001  Jan 0.24  
Sleep duration  
-0.004 (-
0.004) 
>0.05  
-0.046 
(0.015) 
<0.01  -6.0  10.0 <0.01  Mar 0.04  
Fruit and vegetable 
intake 
 
0.058 (-
0.015) 
<0.001  
0.335 (-
0.052) 
<0.001  -38.1  42.1 <0.001  Jul 0.20  
                
Seasonality was indicated by statistical significance of the estimated cosinor (sine and cosine) regression coefficients, and by improved fit 
following addition of the cosinor terms to Model 2, inferred by AIC and by the likelihood ratio test. The parameter derived from the fitted 
cosinor curve are also shown: acrophase and amplitude. A P value < 0.05 was considered statistically significant. Abbreviations: AIC, 
delta AIC, (difference in Akaike information criterion when the cosinor terms were added to multivariable regression model); BMI, body 
mass index; LR 2, likelihood ratio chi-square test statistic (twice the difference in log likelihood of the multivariable model with and 
without the cosinor terms); NA, not applicable.  Model 1 was adjusted for age, ethnicity, deprivation, location of UK Biobank center, BMI, 
physical activity, sedentary behavior, smoking status, fruit and vegetable intake, alcohol intake, and environmental temperature.  Blood 
parameters were additionally adjusted for the blood analyser.  Blood pressure and the blood parameters were additionally adjusted for the 
time of day of measurement.  Model 2 was adjusted for Model 1 covariates and cosinor terms; Model 1 was used as the reference. 
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